IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,740 | -15.6% | 24,778 | +30.5% | 0.00% | – |
| Q2 2023 | $133,633 | -3.9% | 18,982 | -16.6% | 0.00% | – |
| Q1 2023 | $139,033 | -40.3% | 22,755 | +62.3% | 0.00% | – |
| Q1 2022 | $233,000 | +2.2% | 14,017 | +17.6% | 0.00% | – |
| Q4 2021 | $228,000 | -21.9% | 11,918 | +0.5% | 0.00% | – |
| Q3 2021 | $292,000 | -12.0% | 11,854 | -7.0% | 0.00% | – |
| Q2 2021 | $332,000 | -21.7% | 12,744 | -4.9% | 0.00% | – |
| Q1 2021 | $424,000 | -31.7% | 13,400 | +0.1% | 0.00% | – |
| Q4 2020 | $621,000 | +29.1% | 13,392 | -8.3% | 0.00% | – |
| Q3 2020 | $481,000 | +34.4% | 14,612 | +12.2% | 0.00% | – |
| Q2 2020 | $358,000 | +6.5% | 13,025 | +16.2% | 0.00% | – |
| Q1 2020 | $336,000 | – | 11,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |